Time to reconsider the classification of multiple sclerosis
- PMID: 36410374
- DOI: 10.1016/S1474-4422(22)00469-0
Time to reconsider the classification of multiple sclerosis
Conflict of interest statement
I have been supported by a grant from AMED-CREST for basic research on the role of the gut microbiome in multiple sclerosis; received research support from Novartis and Chiome Bioscience; and received speaker honoraria from Novartis, Biogen, Chugai, Alexion, Mitsubishi-Tanabe, and Takeda.
Comment on
-
Multiple sclerosis progression: time for a new mechanism-driven framework.Lancet Neurol. 2023 Jan;22(1):78-88. doi: 10.1016/S1474-4422(22)00289-7. Epub 2022 Nov 18. Lancet Neurol. 2023. PMID: 36410373 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
